Pamlab LLC Release: Data Affirms Long Term Benefit of Adding L-methylfolate to An Antidepressant — Genetic Markers Identified, BMI Possible Predictor of Efficacy

Published: Nov 09, 2011

LAS VEGAS--(BUSINESS WIRE)--Data presented today at the 24th annual U.S. Psychiatric and Mental Health Congress add to the body of evidence suggesting that Deplin® (L-methylfolate 15 mg) is an effective and safe agent for the nutritional management of metabolic imbalances in major depressive disorder (MDD) when used in addition to an antidepressant.

Back to news